NanoViricides
NNVC
#10253
Rank
โ‚น1.85 B
Marketcap
โ‚น85.93
Share price
-5.59%
Change (1 day)
-16.98%
Change (1 year)

NanoViricides (NNVC) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น0.10 Billion

According to NanoViricides's latest financial reports the company has โ‚น0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NanoViricides - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-06-30โ‚น0.13 B-66.6%
2024-06-30โ‚น0.39 B-40.19%
2023-06-30โ‚น0.66 B-39.79%
2022-06-30โ‚น1.11 B-27.21%
2021-06-30โ‚น1.52 B46.94%
2020-06-30โ‚น1.03 B489.49%
2019-06-30โ‚น0.17 B-63.66%
2018-06-30โ‚น0.48 B-50.32%
2017-06-30โ‚น0.97 B-40.18%
2016-06-30โ‚น1.63 B-18.49%
2015-06-30โ‚น2.00 B-9.07%
2014-06-30โ‚น2.20 B165.53%
2013-06-30โ‚น0.82 B4.59%
2012-06-30โ‚น0.79 B92.65%
2011-06-30โ‚น0.41 B27.42%
2010-06-30โ‚น0.32 B299.31%
2009-06-30โ‚น80.84 M130.72%
2008-06-30โ‚น35.03 M-10.68%
2007-06-30โ‚น39.22 M-66.23%
2006-06-30โ‚น0.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
โ‚น910.89 B 853,849.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.380 T 1,293,750.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.011 T 948,012.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น403.12 B 377,820.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น69.65 B 65,199.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น26.03 B 24,306.55%๐Ÿ‡บ๐Ÿ‡ธ USA